The new Congress is taking a long, hard look at biotechnology. A number of proposals will be debated in committee rooms and on the floors of the House and Senate this year, proposals which could have important effects upon the negotiation, funding, and commercialization of biotechnology research.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Garmon, L. How the New Congress will Legislate Biotech. Nat Biotechnol 1, 26–29 (1983). https://doi.org/10.1038/nbt0383-26
Issue Date:
DOI: https://doi.org/10.1038/nbt0383-26